Scienture Holdings Stock Is Soaring Thursday: What's Fueling The Momentum?

Benzinga10-24

Shares of Scienture Holdings, Inc. (NASDAQ:SCNX) are rising Thursday after the comprehensive pharmaceutical product company announced the start of commercial sales for Arbli. What To Know: Scienture ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2577825125?lang=en_US&edition=fundamental","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/10/23/Genetic-Research-And-Biotech-Science-Con.jpeg?optimize=medium&dpr=2&auto=webp&width=260","is_english":true,"pubTime":"2025-10-24 01:14","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2577825125","market":"nz","top_or_hot":-1,"title":"Scienture Holdings Stock Is Soaring Thursday: What's Fueling The Momentum?","media":"Benzinga","content":"<div>\n<p>Shares of Scienture Holdings, Inc. (NASDAQ:SCNX) are rising Thursday after the comprehensive pharmaceutical product company announced the start of commercial sales for Arbli.\nWhat To Know: Scienture ...</p>\n\n<a href=\"https://www.benzinga.com/trading-ideas/movers/25/10/48387214/scienture-holdings-stock-is-soaring-thursday-whats-fueling-the-momentum\">Source Link</a>\n\n</div>\n","source":"benzinga_hot_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Scienture Holdings Stock Is Soaring Thursday: What's Fueling The Momentum?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nScienture Holdings Stock Is Soaring Thursday: What's Fueling The Momentum?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-10-24 01:14 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/trading-ideas/movers/25/10/48387214/scienture-holdings-stock-is-soaring-thursday-whats-fueling-the-momentum><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Shares of Scienture Holdings, Inc. (NASDAQ:SCNX) are rising Thursday after the comprehensive pharmaceutical product company announced the start of commercial sales for Arbli.\nWhat To Know: Scienture ...</p>\n\n<a href=\"https://www.benzinga.com/trading-ideas/movers/25/10/48387214/scienture-holdings-stock-is-soaring-thursday-whats-fueling-the-momentum\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4167","symbol_name":"医疗保健技术","start_time":0,"source_url":"https://www.benzinga.com/trading-ideas/movers/25/10/48387214/scienture-holdings-stock-is-soaring-thursday-whats-fueling-the-momentum","article_id":"2577825125","we_media_id":null,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/10/23/Genetic-Research-And-Biotech-Science-Con.jpeg?optimize=medium&dpr=2&auto=webp&width=260"],"rights":{"source":"benzinga_hot_news","url":"https://www.benzinga.com/trading-ideas/movers/25/10/48387214/scienture-holdings-stock-is-soaring-thursday-whats-fueling-the-momentum","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2577825125","pubTimestamp":1761239640,"columns":[],"sourceInfo":{"source_id":"benzinga_hot_news","name":"Benzinga"},"weMediaInfo":null,"summary":"Shares of Scienture Holdings, Inc. (NASDAQ: SCNX) are rising Thursday after the company announced the start of commercial sales for Arbli.","collect":0,"end_time":0,"defaultTopTitle":"benzinga.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4167":"医疗保健技术","RSI":"Rush Street Interactive, Inc.","BK4150":"赌场与赌博","SCNX":"Scienture Holdings, Inc."},"translate_title":"科学控股股价周四飙升：是什么推动了这一势头？","themeId":"b001d33512a1f41b2399b1de7f7c2a88","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"RSI":1,"SCNX":1},"content_text":"Shares of Scienture Holdings, Inc. (NASDAQ:SCNX) are rising Thursday after the comprehensive pharmaceutical product company announced the start of commercial sales for Arbli.\nWhat To Know: Scienture said it started commercial sales and fulfillment of the first customer orders for Arbli (losartan potassium) oral suspension, 10 mg/mL, marking the first time the company has brought the drug to market.\nShares of Scienture Holdings jumped more than 140% following an exclusive report from Benzinga detailing the announcement.\nArbli is the first FDA-approved, ready-to-use oral suspension formulation of losartan potassium. It’s designed for patients requiring an alternative to solid dosage forms. According to IQVIA data, the U.S. losartan market totals approximately $256 million in annual sales, with more than 71 million prescriptions written each year.\nScienture is executing targeted outreach for Arbli to healthcare professionals and has finalized agreements for expanded commercial coverage and formulary access. It has also formalized multiple commercial group purchasing organization agreements, expanding Arbli’s market access to over 2,500 healthcare institutions nationwide, including hospitals, clinics and nursing homes.\n“The start of commercial sales for Arbli represents a major achievement for Scienture as we transition from development to execution,” said Narasimhan Mani, co-CEO of Scienture. “As promotional efforts expand and demand builds across retail, institutional and long-term care markets, we see significant potential for sustained adoption and value creation.”\nSCNX Analysis: Scienture stock is trading significantly above the 50-day moving average of 90 cents, indicating short-term bullish momentum despite remaining below the 200-day moving average of $1.70, suggesting a longer-term bearish trend.\nThe relative strength index (RSI) stands at 25.22, indicating that the stock is in oversold territory, which could imply potential for continued upward price movement. Given the absence of calculated support levels, the 50-day moving average serves as a critical support point for the stock. If Scienture manages to maintain its current price above this level, it may establish a foundation for further upward movement.\nSCNX Price Action: Scienture shares were up 141.43% at $1.38 at the time of publication on Thursday, according to Benzinga Pro. The stock has a 52-week range of 46 cents to $9.55.\nRead More:\nImage: Shutterstock.com\nThis content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2577825125","isCrawlerRequest":true}